CA2344768A1 - Peptides derives d'antigene humain et leurs utilisations - Google Patents

Peptides derives d'antigene humain et leurs utilisations Download PDF

Info

Publication number
CA2344768A1
CA2344768A1 CA002344768A CA2344768A CA2344768A1 CA 2344768 A1 CA2344768 A1 CA 2344768A1 CA 002344768 A CA002344768 A CA 002344768A CA 2344768 A CA2344768 A CA 2344768A CA 2344768 A1 CA2344768 A1 CA 2344768A1
Authority
CA
Canada
Prior art keywords
cells
subject
immunogenic peptide
hla
sclc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002344768A
Other languages
English (en)
Inventor
Romain K. Gherardi
Francisco Garcia-Pons
Jean-Pierre Farcet
Anne Bourguin-Plonquet
Pierre Langlade-Demoyen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to CA002344768A priority Critical patent/CA2344768A1/fr
Priority to CA002387391A priority patent/CA2387391A1/fr
Publication of CA2344768A1 publication Critical patent/CA2344768A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/55—Lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002344768A 2001-05-08 2001-05-08 Peptides derives d'antigene humain et leurs utilisations Abandoned CA2344768A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002344768A CA2344768A1 (fr) 2001-05-08 2001-05-08 Peptides derives d'antigene humain et leurs utilisations
CA002387391A CA2387391A1 (fr) 2001-05-08 2002-05-08 Peptides derives d'antigene humain et leurs utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002344768A CA2344768A1 (fr) 2001-05-08 2001-05-08 Peptides derives d'antigene humain et leurs utilisations

Publications (1)

Publication Number Publication Date
CA2344768A1 true CA2344768A1 (fr) 2002-11-08

Family

ID=4168887

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002344768A Abandoned CA2344768A1 (fr) 2001-05-08 2001-05-08 Peptides derives d'antigene humain et leurs utilisations

Country Status (1)

Country Link
CA (1) CA2344768A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118909143A (zh) * 2024-10-12 2024-11-08 成都海默云因医学检验实验室有限公司 一种重组蛋白及其用细胞免疫荧光法在抗Hu抗体中的应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118909143A (zh) * 2024-10-12 2024-11-08 成都海默云因医学检验实验室有限公司 一种重组蛋白及其用细胞免疫荧光法在抗Hu抗体中的应用
CN118909143B (zh) * 2024-10-12 2024-12-13 成都海默云因医学检验实验室有限公司 一种重组蛋白及其用细胞免疫荧光法在抗Hu抗体中的应用

Similar Documents

Publication Publication Date Title
JP5182770B2 (ja) Ｍｈｃ分子を結合する腫瘍関連ペプチド
US7148326B2 (en) Tumor antigen
EP1210430B1 (fr) Peptides derives de muc-1
AU2008290061B2 (en) CDCA1 peptide and pharmaceutical agent comprising the same
US20020164346A1 (en) Altered peptide ligands
US20020018766A1 (en) Genes differentially expressed in cancer cells to design cancer vaccines
CN111032686B (zh) 血液恶性肿瘤的治疗
JP2003521245A (ja) ペプチドおよび核酸組成物を使用する、前立腺癌抗原に対する細胞性免疫応答の誘導
JP2004500059A (ja) ペプチドおよび核酸組成物を使用する、癌胎児性抗原に対する細胞性免疫応答の誘導
US20220313803A1 (en) Novel neoantigens and cancer immunotherapy using same
JP2009195235A (ja) 免疫エフェクター細胞ハイブリッド
JP2003517310A (ja) ペプチドおよび核酸組成物を使用する、ｍａｇｅ２／３に対する細胞性免疫応答の誘導
Plonquet et al. Peptides derived from the onconeural HuD protein can elicit cytotoxic responses in HHD mouse and human
JP4779067B2 (ja) ＨＬＡ−Ａ２４０２拘束性Ｅｐ−ＣＡＭ特異的ＣＴＬが認識するエピトープ・ペプチド及びその用途
AU3102299A (en) Compositions and methods for gene-based vaccines to provoke T cell responses
AU755156B2 (en) Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
CA2344768A1 (fr) Peptides derives d'antigene humain et leurs utilisations
CA2387391A1 (fr) Peptides derives d'antigene humain et leurs utilisations
AU767391B2 (en) Peptides related to an IGF-II-R epitope, polynucleotides encoding the peptides, and their use in immunomodulation
CN116710126A (zh) 冠状病毒疫苗和使用方法
WO2000020457A9 (fr) Peptides apparentes a un epitope igf-ii-r, polynucleotides codant ces peptides, et utilisation de ceux-ci dans l'immunomodulation
JP2025508970A (ja) Ｈｌａ－ａ＊０２：０１制限ヒト前立腺酸性ホスファターゼ（ｐａｐ）エピトープとの反応性を示すヒトｔ細胞受容体対
EP1309625B1 (fr) Composes therapeutiques contre le cancer des ovaires

Legal Events

Date Code Title Description
FZDE Discontinued